PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking
- First Posted Date
- 2008-03-13
- Last Posted Date
- 2008-04-10
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 30
- Registration Number
- NCT00635401
- Locations
- 🇯🇵
Pfizer Investigational Site, Oita, Japan
Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma
- First Posted Date
- 2008-03-13
- Last Posted Date
- 2008-04-07
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 73
- Registration Number
- NCT00635323
- Locations
- 🇨🇳
Pfizer Investigational Site, Taipei, Taiwan
Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis
- Conditions
- Arthritis, Rheumatoid
- Interventions
- First Posted Date
- 2008-03-13
- Last Posted Date
- 2013-03-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 222
- Registration Number
- NCT00634933
- Locations
- 🇷🇸
Pfizer Investigational Site, Niska Banja, Serbia
CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery
- Conditions
- Breast Cancer
- First Posted Date
- 2008-03-13
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00635245
A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes
- First Posted Date
- 2008-03-07
- Last Posted Date
- 2015-03-05
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 249
- Registration Number
- NCT00630851
- Locations
Pfizer Investigational Site
Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects
- Conditions
- Renal Cell Carcinoma
- Interventions
- First Posted Date
- 2008-03-07
- Last Posted Date
- 2016-04-27
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 791
- Registration Number
- NCT00631371
- Locations
- 🇭🇺
Uzsoki Utcai Korhaz, Budapest, Hungary
🇨🇱Fundacion Arturo Lopez Perez, Santiago, Chile
🇭🇰Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong
Study Of Sunitinib In Combination With Folfox In Patients With Colorectal Cancer
- First Posted Date
- 2008-03-07
- Last Posted Date
- 2011-03-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT00631410
- Locations
- 🇯🇵
Pfizer Investigational Site, Chuo-ku, Tokyo, Japan
Efficacy of Somatropin in Adult Patients With Isolated Growth Hormone Deficiency
- First Posted Date
- 2008-03-07
- Last Posted Date
- 2013-03-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 9
- Registration Number
- NCT00630487
- Locations
- 🇩🇪
Pfizer Investigational Site, Muenchen, Germany
The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis
- Conditions
- Transthyretin-associated Amyloidosis With Polyneuropathy
- Interventions
- First Posted Date
- 2008-03-07
- Last Posted Date
- 2013-01-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 21
- Registration Number
- NCT00630864
- Locations
- 🇫🇷
CHU de Bicetre, Paris, France
🇺🇸Johns Hopkins Hospital, Baltimore, Maryland, United States
🇩🇪Universitatsklinikum Munster, Transplant Hepatology, Munster, Germany
Transthyretin Amyloidosis Outcome Survey (THAOS)
- Conditions
- Transthyretin Gene MutationsTransthyretin Amyloidosis
- Interventions
- Other: None. Observational Study.
- First Posted Date
- 2008-03-05
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 6718
- Registration Number
- NCT00628745
- Locations
- 🇺🇸
The University of Utah Health Sciences Center, Salt Lake City, Utah, United States
🇺🇸Medical College of Wisconsin, Milwaukee, Wisconsin, United States
🇦🇷Hospital Italiano de Buenos Aires (HIBA), Buenos Aires, Argentina